Chris Hart Joins NorthStar Medical Radioisotopes, LLC as Vice President, Human Resources

BELOIT, Wis., April 15, 2025 – NorthStar Medical Radioisotopes, LLC, a global innovator in the development, production and commercialization of radiopharmaceuticals used for therapeutic applications and medical imaging, announced that Chris Hart, JD has joined the company as Vice President, Human Resources. In this role, Hart will be responsible for developing and implementing HR strategies that reflect NorthStar’s culture and support the company’s mission and objectives. Hart will also oversee the company’s recruitment, talent management, and retention programs to help NorthStar attract and retain a skilled workforce.

Hart brings over 15 years of HR management experience to NorthStar, serving in leadership positions in the commercial plumbing and electrical industries. In these roles, Hart has managed large HR teams and successfully led key strategic HR disciplines such as talent acquisition and management, labor and employment relations, and field human resources.

Commenting on Hart’s appointment, Frank Scholz, President and CEO of NorthStar Medical Radioisotopes said, “NorthStar is very pleased to have added an individual with Chris’s skills and experience to our leadership team. NorthStar is a company built on a highly skilled and specialized workforce and Chris’s experience in identifying and retaining individuals with solid educational backgrounds and practical experience will be key to our future growth. We’re glad to have him with us.”

Commenting on joining an emerging leader in the development of innovative radiopharmaceutical diagnostic agents and treatment, Hart said, “NorthStar was intriguing to me because of its mission and for the opportunity to work with such an engaged and highly skilled team. Our capability and our infrastructure are only matched by our employees’ motivation to make a difference in patients’ lives. NorthStar’s state-of-the-art technology and the expertise of our people set us apart in the radiopharmaceutical industry, and I’ve never worked with a group of people that are so aligned on a common goal to make game changing radiopharmaceuticals available to patients around the world.”

Hart holds a Juris Doctorate from Chicago-Kent College of Law, a Master of Science degree in Human Resources from Loyola University Chicago, and a Bachelor of Science degree in Communication from the University of Illinois at Urbana-Champaign.

About NorthStar Medical Radioisotopes, LLC (NorthStar)
NorthStar Medical Radioisotopes is a commercial-stage radiopharmaceutical company at the forefront of advancing patient care by utilizing novel technologies to produce commercial-scale radioisotopes that, once attached to a molecule, have the ability to detect and treat cancer and other serious diseases. NorthStar’s expanding industry-leading position in the emerging field of radiopharmaceutical therapy is supported by its unique capabilities in the sophisticated production of radioisotopes, proven management team, and state-of-the-art, environmentally preferable technologies. NorthStar produces copper-67 (Cu-67) and is poised to be one of the first commercial-scale producers of non-carrier added actinium-225 (n.c.a. Ac-225). The Company’s Radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) services unit provides customized service offerings and specialized radiopharmaceutical expertise to help biopharmaceutical companies rapidly advance their development and commercial programs. For more information about NorthStar’s comprehensive portfolio and patient-focused services. Visit: www.northstarnm.com.

NorthStar Medical Radioisotopes, LLC Contact:
Corporate:
Alison Hess
Vice President, Chief of Staff
608-295-9806
[email protected]